GGrantIndex
← Leaderboards

Laurie T Krug

State University New York Stony Brook

$2,581,773
Attributed
$2,958,305
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $767.3K · FY201218
$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$2,958,305 · 4

By mechanism

R01$1,778,264 · 1
R21$873,764 · 2
R43$306,277 · 1

Top collaborators

Most similar at State University New York Stony Brook

Same institution · by research overlap

Others in their field

Top investigators on “Virus

Research focus

VirusGammaherpesvirusMalignant NeoplasmsPathogenHerpesviridaeB-LymphocytesInfectionCellsHuman Herpesvirus 4Human Herpesvirus 8ProgramsMolecularGenesOncogenicPathogenesisHerpesviridae InfectionsMortalityMorbidity - Disease RateT-LymphocyteViralAnimalsAnimal ModelKaposi SarcomaPrimary Effusion Lymphoma

Grant awards (25)

Investigation of viral and host determinants of gammaherpesvirus pathogenesis$1,086,648
ZIA · FY2025 · CA · contact PI
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies$1,086,648
ZIA · FY2025 · CA · contact PI
Strategic Herpesvirus Immune Evasion and Latency Defense$841,276
ZIA · FY2025 · CA · contact PI
Viral and Genetic Drivers of Growth and Metastasis of Anaplastic Kaposi Sarcoma in People Living with HIV$636,944
ZIA · FY2025 · CA · contact PI
Single-cell Analysis of Primary Effusion Lymphoma Patient-Derived Xenografts from HIV-AIDS Patients to Identify Molecular Targets for Intervention$113,716
ZIA · FY2025 · CA · contact PI
Investigation of viral and host determinants of gammaherpesvirus pathogenesis$1,343,174
ZIA · FY2024 · CA · contact PI
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies$413,285
ZIA · FY2024 · CA · contact PI
Strategic Herpesvirus Immune Evasion and Latency Defense$309,964
ZIA · FY2024 · CA · contact PI
Investigation of viral and host determinants of gammaherpesvirus pathogenesis$1,358,576
ZIA · FY2023 · CA · contact PI
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies$552,560
ZIA · FY2023 · CA · contact PI
Investigation of viral and host determinants of gammaherpesvirus pathogenesis$1,449,199
ZIA · FY2022 · CA · contact PI
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies$255,740
ZIA · FY2022 · CA · contact PI
Investigation of viral and host determinants of gammaherpesvirus pathogenesis$1,269,469
ZIA · FY2021 · CA · contact PI
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies$224,024
ZIA · FY2021 · CA · contact PI
Investigation of viral and host determinants of gammaherpesvirus pathogenesis$1,559,522
ZIA · FY2020 · CA · contact PI
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies$173,281
ZIA · FY2020 · CA · contact PI
Functional Analysis of STAT3 in Gammaherpesvirus Infection$442,051
R01 · FY2018 · AI · contact PI
Functional Analysis of STAT3 in Gammaherpesvirus Infection$461,011
R01 · FY2017 · AI · contact PI
CRISPR-Cas9 Systems Delivered by Targeted Nanoparticles to Eradicate Herpesvirus Pathogens$306,277
R43 · FY2017 · AI
Functional Analysis of STAT3 in Gammaherpesvirus Infection$437,601
R01 · FY2016 · AI · contact PI
Functional Analysis of STAT3 in Gammaherpesvirus Infection$437,601
R01 · FY2015 · AI · contact PI
Uracil DNA glycosylases in herpesvirus pathogenesis and DNA mutation$236,071
R21 · FY2015 · AI · contact PI
Uracil DNA glycosylases in herpesvirus pathogenesis and DNA mutation$210,717
R21 · FY2014 · AI · contact PI
Function of gammaherpesvirus ORF75 tegument proteins$233,113
R21 · FY2013 · AI · contact PI
Function of gammaherpesvirus ORF75 tegument proteins$193,863
R21 · FY2012 · AI · contact PI